A	O
Case	O
Presenting	O
with	O
Splenic	B:C0037998
Infarct	I:C0037998
Diagnosed	O
as	O
Primary	O
Bone	I:C0005953
Marrow	I:C0005953
CD5	O
Positive	I:C0882892
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
:	O
A	O
Clinicopathological	O
Correlation	O
.	O

A	O
Case	O
Presenting	O
with	O
Splenic	O
Infarct	I:C0037998
Diagnosed	B:C0011900
as	O
Primary	O
Bone	I:C0005953
Marrow	I:C0005953
CD5	O
Positive	I:C0882892
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
:	O
A	O
Clinicopathological	O
Correlation	O
.	O

A	O
Case	O
Presenting	O
with	O
Splenic	O
Infarct	I:C0037998
Diagnosed	O
as	O
Primary	B:C0005953
Bone	I:C0005953
Marrow	I:C0005953
CD5	O
Positive	I:C0882892
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
:	O
A	O
Clinicopathological	O
Correlation	O
.	O

A	O
Case	O
Presenting	O
with	O
Splenic	O
Infarct	I:C0037998
Diagnosed	O
as	O
Primary	O
Bone	I:C0005953
Marrow	I:C0005953
CD5	B:C0882892
Positive	I:C0882892
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
:	O
A	O
Clinicopathological	O
Correlation	O
.	O

A	O
Case	O
Presenting	O
with	O
Splenic	O
Infarct	I:C0037998
Diagnosed	O
as	O
Primary	O
Bone	I:C0005953
Marrow	I:C0005953
CD5	O
Positive	I:C0882892
Diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
:	O
A	O
Clinicopathological	O
Correlation	O
.	O

De	O
novo	O
CD5	B:C0882892
+	I:C0882892

Diffuse	B:C0011900
large	I:C0011900
B	I:C0011900
cell	I:C0011900
lymphoma	I:C0011900
(	O
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
)	O
is	O
a	O
rare	O
and	O
aggressive	O
subtype	I:C0243095
of	O
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
.	O

Diffuse	O
large	I:C0011900
B	I:C0011900
cell	I:C0011900
lymphoma	I:C0011900
(	O
Diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
)	O
is	O
a	O
rare	O
and	O
aggressive	O
subtype	I:C0243095
of	O
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
.	O

Diffuse	O
large	I:C0011900
B	I:C0011900
cell	I:C0011900
lymphoma	I:C0011900
(	O
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
)	O
is	O
a	O
rare	O
and	O
aggressive	B:C0243095
subtype	I:C0243095
of	O
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
.	O

Diffuse	O
large	I:C0011900
B	I:C0011900
cell	I:C0011900
lymphoma	I:C0011900
(	O
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
)	O
is	O
a	O
rare	O
and	O
aggressive	O
subtype	I:C0243095
of	O
Diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
.	O

It	O
is	O
a	O
distinct	O
clinicopathologic	B:C0243095
entity	O
with	O
complex	O
molecular	O
profile	O
and	O
poor	O
prognosis	I:C0278252
.	O

It	O
is	O
a	O
distinct	O
clinicopathologic	O
entity	O
with	O
complex	O
molecular	O
profile	O
and	O
poor	B:C0278252
prognosis	I:C0278252
.	O

A	O
59	O
year	O
old	O
female	O
presented	B:C0150312
with	I:C0150312
pyrexia	O
of	I:C0015970
unknown	I:C0015970
origin	I:C0015970
since	O
1	O
month	O
.	O

A	O
59	O
year	O
old	O
female	O
presented	O
with	I:C0150312
pyrexia	B:C0015970
of	I:C0015970
unknown	I:C0015970
origin	I:C0015970
since	O
1	O
month	O
.	O

On	O
examination	B:C0031809
,	O
there	O
was	O
severe	O
pallor	I:C0030232
,	O
hepatosplenomegaly	O
and	O
no	O
palpable	O
lymphadenopathy	O
.	O

On	O
examination	O
,	O
there	O
was	O
severe	B:C0030232
pallor	I:C0030232
,	O
hepatosplenomegaly	O
and	O
no	O
palpable	O
lymphadenopathy	O
.	O

On	O
examination	O
,	O
there	O
was	O
severe	O
pallor	I:C0030232
,	O
hepatosplenomegaly	B:C0019214
and	O
no	O
palpable	O
lymphadenopathy	O
.	O

On	O
examination	O
,	O
there	O
was	O
severe	O
pallor	I:C0030232
,	O
hepatosplenomegaly	O
and	O
no	O
palpable	O
lymphadenopathy	B:C0497156
.	O

Complete	B:C0009555
blood	I:C0009555
count	I:C0009555
revealed	O
bicytopenia	O
with	O
normal	O
total	I:C0438221
leucocyte	I:C0438221
count	I:C0438221
.	O

Complete	O
blood	I:C0009555
count	I:C0009555
revealed	O
bicytopenia	B:C1142446
with	O
normal	O
total	I:C0438221
leucocyte	I:C0438221
count	I:C0438221
.	O

Complete	O
blood	I:C0009555
count	I:C0009555
revealed	O
bicytopenia	O
with	O
normal	B:C0438221
total	I:C0438221
leucocyte	I:C0438221
count	I:C0438221
.	O

Liver	B:C0023901
and	O
renal	O
function	I:C0022662
tests	I:C0022662
were	O
normal	O
.	O

Liver	O
and	O
renal	B:C0022662
function	I:C0022662
tests	I:C0022662
were	O
normal	O
.	O

Ultrasonography	B:C0203464
abdomen	I:C0203464
revealed	O
splenic	O
enlargement	I:C0038002
with	O
two	O
focal	I:C0243095
lesions	I:C0243095
attributed	O
to	O
either	O
splenic	O
abscess	I:C0272412
or	O
infarcts	O
.	O

Ultrasonography	O
abdomen	I:C0203464
revealed	O
splenic	B:C0038002
enlargement	I:C0038002
with	O
two	O
focal	I:C0243095
lesions	I:C0243095
attributed	O
to	O
either	O
splenic	O
abscess	I:C0272412
or	O
infarcts	O
.	O

Ultrasonography	O
abdomen	I:C0203464
revealed	O
splenic	O
enlargement	I:C0038002
with	O
two	B:C0243095
focal	I:C0243095
lesions	I:C0243095
attributed	O
to	O
either	O
splenic	O
abscess	I:C0272412
or	O
infarcts	O
.	O

Ultrasonography	O
abdomen	I:C0203464
revealed	O
splenic	O
enlargement	I:C0038002
with	O
two	O
focal	I:C0243095
lesions	I:C0243095
attributed	O
to	O
either	O
splenic	B:C0272412
abscess	I:C0272412
or	O
infarcts	O
.	O

Ultrasonography	O
abdomen	I:C0203464
revealed	O
splenic	O
enlargement	I:C0038002
with	O
two	O
focal	I:C0243095
lesions	I:C0243095
attributed	O
to	O
either	O
splenic	O
abscess	I:C0272412
or	O
infarcts	B:C0037998
.	O

Patient	O
was	O
being	O
managed	O
as	O
splenic	B:C0037998
infarct	I:C0037998
but	O
continued	O
to	O
have	O
bicytopenia	O
.	O

Patient	O
was	O
being	O
managed	O
as	O
splenic	O
infarct	I:C0037998
but	O
continued	O
to	O
have	O
bicytopenia	B:C1142446
.	O

Further	O
investigation	B:C0220825
showed	O
elevated	O
serum	I:C0241013
ferritin	I:C0241013
,	O
triglycerides	O
and	O
LDH	O
.	O

Further	O
investigation	O
showed	O
elevated	B:C0241013
serum	I:C0241013
ferritin	I:C0241013
,	O
triglycerides	O
and	O
LDH	O
.	O

Further	O
investigation	O
showed	O
elevated	O
serum	I:C0241013
ferritin	I:C0241013
,	O
triglycerides	B:C0813230
and	O
LDH	O
.	O

Further	O
investigation	O
showed	O
elevated	O
serum	I:C0241013
ferritin	I:C0241013
,	O
triglycerides	O
and	O
LDH	B:C1275604
.	O

With	O
a	O
clinical	O
suspicion	B:C0242114
of	O
infection	O
and	O
haemophagocytic	O
lymphohistiocytosis	I:C0024291
bone	O
marrow	I:C0005954
aspiration	I:C0005954
(	I:C0005954
BMA	I:C0005954
)	I:C0005954
and	I:C0005954
biopsy	I:C0005954
(	I:C0005954
BMBx	I:C0005954
)	I:C0005954
was	O
done	O
.	O

With	O
a	O
clinical	O
suspicion	O
of	O
infection	B:C3714514
and	O
haemophagocytic	O
lymphohistiocytosis	I:C0024291
bone	O
marrow	I:C0005954
aspiration	I:C0005954
(	I:C0005954
BMA	I:C0005954
)	I:C0005954
and	I:C0005954
biopsy	I:C0005954
(	I:C0005954
BMBx	I:C0005954
)	I:C0005954
was	O
done	O
.	O

With	O
a	O
clinical	O
suspicion	O
of	O
infection	O
and	O
haemophagocytic	B:C0024291
lymphohistiocytosis	I:C0024291
bone	O
marrow	I:C0005954
aspiration	I:C0005954
(	I:C0005954
BMA	I:C0005954
)	I:C0005954
and	I:C0005954
biopsy	I:C0005954
(	I:C0005954
BMBx	I:C0005954
)	I:C0005954
was	O
done	O
.	O

With	O
a	O
clinical	O
suspicion	O
of	O
infection	O
and	O
haemophagocytic	O
lymphohistiocytosis	I:C0024291
bone	B:C0005954
marrow	I:C0005954
aspiration	I:C0005954
(	I:C0005954
BMA	I:C0005954
)	I:C0005954
and	I:C0005954
biopsy	I:C0005954
(	I:C0005954
BMBx	I:C0005954
)	I:C0005954
was	O
done	O
.	O

BMA	O
showed	O
extensive	O
haemophagocytosis	B:C0876991
and	O
~	O
7.4	O
%	O
large	O
lymphoma	I:C0027671
-	I:C0027671
like	I:C0027671
cells	I:C0027671
.	O

BMA	O
showed	O
extensive	O
haemophagocytosis	O
and	O
~	O
7.4	O
%	O
large	B:C0027671
lymphoma	I:C0027671
-	I:C0027671
like	I:C0027671
cells	I:C0027671
.	O

On	O
this	O
basis	O
PET	B:C1699633
-	I:C1699633
CT	I:C1699633
was	O
suggested	O
which	O
showed	O
enlarged	O
spleen	I:C0038002
with	O
diffuse	O
uptake	I:C0301639
.	O

On	O
this	O
basis	O
PET	O
-	I:C1699633
CT	I:C1699633
was	O
suggested	O
which	O
showed	O
enlarged	B:C0038002
spleen	I:C0038002
with	O
diffuse	O
uptake	I:C0301639
.	O

On	O
this	O
basis	O
PET	O
-	I:C1699633
CT	I:C1699633
was	O
suggested	O
which	O
showed	O
enlarged	O
spleen	I:C0038002
with	O
diffuse	B:C0301639
uptake	I:C0301639
.	O

BMBx	B:C0005954
showed	O
nodular	O
and	O
intrasinusoidal	O
collection	O
of	O
abnormal	O
lymphoid	I:C0086574
cells	I:C0086574
.	O

BMBx	O
showed	O
nodular	B:C0028259
and	O
intrasinusoidal	O
collection	O
of	O
abnormal	O
lymphoid	I:C0086574
cells	I:C0086574
.	O

BMBx	O
showed	O
nodular	O
and	O
intrasinusoidal	B:C0442041
collection	O
of	O
abnormal	O
lymphoid	I:C0086574
cells	I:C0086574
.	O

BMBx	O
showed	O
nodular	O
and	O
intrasinusoidal	O
collection	O
of	O
abnormal	B:C0086574
lymphoid	I:C0086574
cells	I:C0086574
.	O

On	O
immunohistochemistry	B:C0021044
,	O
these	O
cells	O
were	O
positive	O
for	I:C4289894
CD20	I:C4289894
,	O
CD5	O
,	O
MUM1	O
,	O
BCL	O
-	O
2	O
,	O
BCL	O
-	O
6	O
and	O
negative	O
for	O
CD3	O
,	O
CD10	O
and	O
CD23	O
.	O

On	O
immunohistochemistry	O
,	O
these	O
cells	B:C0086574
were	O
positive	O
for	I:C4289894
CD20	I:C4289894
,	O
CD5	O
,	O
MUM1	O
,	O
BCL	O
-	O
2	O
,	O
BCL	O
-	O
6	O
and	O
negative	O
for	O
CD3	O
,	O
CD10	O
and	O
CD23	O
.	O

On	O
immunohistochemistry	O
,	O
these	O
cells	O
were	O
positive	B:C4289894
for	I:C4289894
CD20	I:C4289894
,	O
CD5	O
,	O
MUM1	O
,	O
BCL	O
-	O
2	O
,	O
BCL	O
-	O
6	O
and	O
negative	O
for	O
CD3	O
,	O
CD10	O
and	O
CD23	O
.	O

On	O
immunohistochemistry	O
,	O
these	O
cells	O
were	O
positive	O
for	I:C4289894
CD20	I:C4289894
,	O
CD5	B:C0054964
,	O
MUM1	O
,	O
BCL	O
-	O
2	O
,	O
BCL	O
-	O
6	O
and	O
negative	O
for	O
CD3	O
,	O
CD10	O
and	O
CD23	O
.	O

On	O
immunohistochemistry	O
,	O
these	O
cells	O
were	O
positive	O
for	I:C4289894
CD20	I:C4289894
,	O
CD5	O
,	O
MUM1	B:C0299544
,	O
BCL	O
-	O
2	O
,	O
BCL	O
-	O
6	O
and	O
negative	O
for	O
CD3	O
,	O
CD10	O
and	O
CD23	O
.	O

On	O
immunohistochemistry	O
,	O
these	O
cells	O
were	O
positive	O
for	I:C4289894
CD20	I:C4289894
,	O
CD5	O
,	O
MUM1	O
,	O
BCL	O
-	O
2	O
,	O
BCL	O
-	O
6	O
and	O
negative	B:C0205160
for	O
CD3	O
,	O
CD10	O
and	O
CD23	O
.	O

On	O
immunohistochemistry	O
,	O
these	O
cells	O
were	O
positive	O
for	I:C4289894
CD20	I:C4289894
,	O
CD5	O
,	O
MUM1	O
,	O
BCL	O
-	O
2	O
,	O
BCL	O
-	O
6	O
and	O
negative	O
for	O
CD3	B:C0108779
,	O
CD10	O
and	O
CD23	O
.	O

On	O
immunohistochemistry	O
,	O
these	O
cells	O
were	O
positive	O
for	I:C4289894
CD20	I:C4289894
,	O
CD5	O
,	O
MUM1	O
,	O
BCL	O
-	O
2	O
,	O
BCL	O
-	O
6	O
and	O
negative	O
for	O
CD3	O
,	O
CD10	B:C0025250
and	O
CD23	O
.	O

On	O
immunohistochemistry	O
,	O
these	O
cells	O
were	O
positive	O
for	I:C4289894
CD20	I:C4289894
,	O
CD5	O
,	O
MUM1	O
,	O
BCL	O
-	O
2	O
,	O
BCL	O
-	O
6	O
and	O
negative	O
for	O
CD3	O
,	O
CD10	O
and	O
CD23	B:C0123242
.	O

CD34	B:C0054953
highlighted	O
focal	O
intrasinusoidal	O
pattern	O
.	O

CD34	O
highlighted	O
focal	B:C0205234
intrasinusoidal	O
pattern	O
.	O

CD34	O
highlighted	O
focal	O
intrasinusoidal	B:C0442041
pattern	O
.	O

CD34	O
highlighted	O
focal	O
intrasinusoidal	O
pattern	B:C0449774
.	O

The	O
complete	O
clinicopathological	O
profile	O
suggested	O
the	O
diagnosis	B:C0011900
of	O
de	O
novo	O
CD5	O
+	I:C0882892

The	O
complete	O
clinicopathological	O
profile	O
suggested	O
the	O
diagnosis	O
of	O
de	O
novo	O
CD5	B:C0882892
+	I:C0882892

Diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
,	O
with	O
primary	O
hepatosplenic	I:C0012634
pattern	O
of	O
involvement	O
.	O

Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
,	O
with	O
primary	B:C0012634
hepatosplenic	I:C0012634
pattern	O
of	O
involvement	O
.	O

Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
,	O
with	O
primary	O
hepatosplenic	I:C0012634
pattern	B:C0449774
of	O
involvement	O
.	O

CD5	B:C0882892
+	I:C0882892
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
presenting	O
as	O
splenic	O
infarct	I:C0037998
is	O
very	O
rare	I:C1855575
.	O

CD5	O
+	I:C0882892
Diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
presenting	O
as	O
splenic	O
infarct	I:C0037998
is	O
very	O
rare	I:C1855575
.	O

CD5	O
+	I:C0882892
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
presenting	O
as	O
splenic	B:C0037998
infarct	I:C0037998
is	O
very	O
rare	I:C1855575
.	O

CD5	O
+	I:C0882892
Diffuse	O
large	I:C0079744
B	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
presenting	O
as	O
splenic	O
infarct	I:C0037998
is	O
very	B:C1855575
rare	I:C1855575
.	O

This	O
case	O
was	O
unusual	O
as	O
the	O
diagnosis	B:C0011900
of	O
a	O
primary	O
aggressive	I:C1332225
lymphoma	I:C1332225
with	O
haemophagocytosis	O
was	O
established	O
in	O
a	O
patient	O
who	O
presented	O
with	O
fever	O
and	O
splenic	O
infarct	I:C0037998
without	O
lymphadenopathy	O
.	O

This	O
case	O
was	O
unusual	O
as	O
the	O
diagnosis	O
of	O
a	O
primary	B:C1332225
aggressive	I:C1332225
lymphoma	I:C1332225
with	O
haemophagocytosis	O
was	O
established	O
in	O
a	O
patient	O
who	O
presented	O
with	O
fever	O
and	O
splenic	O
infarct	I:C0037998
without	O
lymphadenopathy	O
.	O

This	O
case	O
was	O
unusual	O
as	O
the	O
diagnosis	O
of	O
a	O
primary	O
aggressive	I:C1332225
lymphoma	I:C1332225
with	O
haemophagocytosis	B:C0876991
was	O
established	O
in	O
a	O
patient	O
who	O
presented	O
with	O
fever	O
and	O
splenic	O
infarct	I:C0037998
without	O
lymphadenopathy	O
.	O

This	O
case	O
was	O
unusual	O
as	O
the	O
diagnosis	O
of	O
a	O
primary	O
aggressive	I:C1332225
lymphoma	I:C1332225
with	O
haemophagocytosis	O
was	O
established	O
in	O
a	O
patient	O
who	O
presented	O
with	O
fever	B:C0015967
and	O
splenic	O
infarct	I:C0037998
without	O
lymphadenopathy	O
.	O

This	O
case	O
was	O
unusual	O
as	O
the	O
diagnosis	O
of	O
a	O
primary	O
aggressive	I:C1332225
lymphoma	I:C1332225
with	O
haemophagocytosis	O
was	O
established	O
in	O
a	O
patient	O
who	O
presented	O
with	O
fever	O
and	O
splenic	B:C0037998
infarct	I:C0037998
without	O
lymphadenopathy	O
.	O

This	O
case	O
was	O
unusual	O
as	O
the	O
diagnosis	O
of	O
a	O
primary	O
aggressive	I:C1332225
lymphoma	I:C1332225
with	O
haemophagocytosis	O
was	O
established	O
in	O
a	O
patient	O
who	O
presented	O
with	O
fever	O
and	O
splenic	O
infarct	I:C0037998
without	O
lymphadenopathy	B:C0497156
.	O

This	O
indicates	O
the	O
importance	O
of	O
good	O
morphological	B:C0543482
assessment	O
of	O
a	O
bone	O
marrow	I:C0857285
aspirate	I:C0857285
and	O
biopsy	O
to	O
make	O
a	O
correct	O
diagnosis	I:C0011900
.	O

This	O
indicates	O
the	O
importance	O
of	O
good	O
morphological	O
assessment	O
of	O
a	O
bone	B:C0857285
marrow	I:C0857285
aspirate	I:C0857285
and	O
biopsy	O
to	O
make	O
a	O
correct	O
diagnosis	I:C0011900
.	O

This	O
indicates	O
the	O
importance	O
of	O
good	O
morphological	O
assessment	O
of	O
a	O
bone	O
marrow	I:C0857285
aspirate	I:C0857285
and	O
biopsy	B:C0005558
to	O
make	O
a	O
correct	O
diagnosis	I:C0011900
.	O

This	O
indicates	O
the	O
importance	O
of	O
good	O
morphological	O
assessment	O
of	O
a	O
bone	O
marrow	I:C0857285
aspirate	I:C0857285
and	O
biopsy	O
to	O
make	O
a	O
correct	B:C0011900
diagnosis	I:C0011900
.	O

